Search clinical trials for: Dasatinib - 1A
Total 1663 results
-
First Affiliated Hospital of Harbin Medical UniversityTerminated
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.; Beijing gene plus technology co., LTDCompleted
-
Shanghai Ninth People's Hospital Affiliated to...UnknownAdenoid Cystic CarcinomaChina
-
Boehringer IngelheimCompleted
-
Shanghai Ninth People's Hospital Affiliated to...UnknownSarcoma | Head and Neck Cancer | Soft Tissue and Bone TumorChina
-
Jiangsu HengRui Medicine Co., Ltd.Sun Yat-sen UniversityCompletedNon-Small-Cell Lung CancerChina
-
Fudan UniversityCompleted
-
Fujian Cancer HospitalNot yet recruiting
-
Fudan UniversityRecruitingGastric Cancer | MetastasisChina
-
Di WuRecruiting
-
Peking University People's HospitalCompleted
-
Guangzhou Institute of Respiratory DiseaseJiangsu HengRui Medicine Co., Ltd.Unknown
-
Cancer Institute and Hospital, Chinese Academy...UnknownSmall Cell Lung CancerChina
-
Tianjin Medical University Cancer Institute and...UnknownDifferentiated Thyroid CarcinomaChina
-
Tianjin Medical University Cancer Institute and...Unknown
-
Tianjin Medical University Cancer Institute and...UnknownMetastatic Renal Cell Carcinoma
-
The First Affiliated Hospital of Zhengzhou UniversityUnknown
-
Medical University of South CarolinaBoehringer IngelheimWithdrawnLung CancerUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.RecruitingHepatocellular CarcinomaChina
-
Zhejiang UniversityRecruitingHepatocellular CarcinomaChina
-
Boehringer IngelheimCompleted
-
Sun Yat-sen UniversityActive, not recruitingNasopharyngeal Carcinoma | Chemotherapy Effect | Immunotherapy | Recurrent Nasopharyngeal Carcinoma | Metastatic Nasopharyngeal Carcinoma | Molecular Targeted TherapyChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHepatocellular CarcinomaChina
-
Boehringer IngelheimNo longer available
-
Hubei Cancer HospitalEnrolling by invitation
-
Peking University Cancer Hospital & InstitutePeking University First Hospital; Shanxi Province Cancer Hospital; Peking University... and other collaboratorsCompleted
-
Peking Union Medical College HospitalJiangsu HengRui Medicine Co., Ltd.CompletedIntrahepatic Cholangiocarcinoma | Second-line TreatmentChina
-
Qianfoshan HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.UnknownImmune Checkpoint InhibitionChina
-
Henan Cancer HospitalUnknownAdvanced Gastric Cancer
-
University College, LondonBoehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungUnited Kingdom
-
GUO WEICompletedOsteosarcoma | MetastasisChina
-
Tianjin Medical University Cancer Institute and...Zhejiang Cancer Hospital; Fudan University; Liaoning Tumor Hospital & Institute; Gansu Cancer HospitalUnknownSoft Tissue Sarcoma, Adult, Stage IIChina
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungKorea, Republic of
-
Boehringer IngelheimTerminatedNeoplasmsUnited States, Taiwan
-
Hebei Medical University Fourth HospitalRecruiting
-
Amsterdam UMC, location VUmcCompletedCancer | Advanced Solid TumorsNetherlands
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis, Relapsing-RemittingGermany
-
National Institute of Allergy and Infectious Diseases...Completed
-
Nancy Hammond, MDKansas City Area Life Sciences Institute, Inc.CompletedMultiple Sclerosis | Low Bone DensityUnited States
-
National Cancer Institute (NCI)CompletedMetastatic Squamous Neck Cancer With Occult Primary | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent... and other conditionsUnited States
-
GlaxoSmithKlineCompletedNeoplasms, Head and NeckSpain, Peru, France, United States, Netherlands, India, Hungary, United Kingdom, Canada
-
University of California, DavisBristol-Myers Squibb; National Cancer Institute (NCI); Genentech, Inc.TerminatedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
St Vincent's Hospital, SydneyRecruitingMetastatic Prostate CancerAustralia
-
Bristol-Myers SquibbPPD; European Organisation for Research and Treatment of Cancer - EORTC; ICON... and other collaboratorsCompletedChronic Phase Chronic Myeloid LeukemiaUnited States, Canada, France, Germany, Italy, Spain
-
Versailles HospitalCompletedLeukemia, Lymphoblastic, AcuteFrance, Italy, Belgium, Germany
-
West China HospitalJiangsu HengRui Medicine Co., Ltd.UnknownApatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLCLung Cancer | Non Small Cell Lung Cancer | Apatinib | Combination ChemotherapyChina
-
Latin American Cooperative Oncology GroupGlaxoSmithKlineCompletedBRMS1 | Performance Status Zero to Two for Beginning the Study | Patient With a Maximum of One Chemotherapy | Patient With Progression After TaxanesArgentina, Brazil, Peru
-
Peking University People's HospitalJiangsu HengRui Medicine Co., Ltd.RecruitingToxicity | Effect of Drug | DrugChina
-
Beijing Chest HospitalNot yet recruiting
-
Henan Cancer HospitalRecruitingCamrelizumab Plus Apatinib as Maintenance Therapy in Extensive-stage Small-cell Lung Cancer (CAMERA)Small Cell Lung CarcinomaChina